Artificial Peptides Block Infectivity of Influenza Virus

News   Sep 29, 2017 | Original story from The Scripps Research Institute (TSRI)

 
Artificial Peptides Block Infectivity of Influenza Virus

The Janssen and TSRI teams designed and characterized a potent peptide that mimicked the functionality of a broadly neutralizing antibody and which was also able to target influenza virus hemagglutinin. Image credit: Rameshwar U. Kadam (Ian Wilson's Lab)

 
 
 

RELATED ARTICLES

Sweet Spot of Activity in Immune System Key to Fighting Cancer

News

Scientists have shown how stimulating a specific location on the surface of immune cells can be targeted with antibodies to help in their fight against cancer.

READ MORE

Compound Offers Pain-relief of Opioids Without Addictive Properties

News

Researchers have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.

READ MORE

E. Coli’s Internal Bomb Offers Chink In Armour

News

Bacteria's internal bomb, the so-called toxin-antitoxin (TA) system that is part of the normal bacterial makeup, may be triggered to make bacteria turn on themselves, providing a valuable target for novel antimicrobial approaches in drug design.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE